PAMU
AGIO icon

Pictet Asset Management (UK)’s Agios Pharmaceuticals AGIO Stock Holding History

Pictet Asset Management (UK)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$5.87M Sell
106,557
-21,851
-17% -$1.22M 0.01% 808
2021
Q1 		$6.63M Buy
128,408
+1,726
+1% +$85.5K 0.01% 772
2020
Q4 		$5.49M Sell
126,682
-5,600
-4% -$221K 0.01% 795
2020
Q3 		$4.63M Buy
132,282
+31,846
+32% +$1.4M 0.01% 744
2020
Q2 		$5.37M Buy
100,436
+11,820
+13% +$547K 0.01% 665
2020
Q1 		$3.14M Buy
88,616
+33,400
+60% +$1.54M 0.01% 759
2019
Q4 		$2.64M Sell
55,216
-3,100
-5% -$117K ﹤0.01% 889
2019
Q3 		$1.89M Sell
58,316
-358,464
-86% -$14.8M ﹤0.01% 871
2019
Q2 		$20.8M Buy
416,780
+53,816
+15% +$2.88M 0.04% 376
2019
Q1 		$24.5M Buy
362,964
+3,338
+0.9% +$194K 0.05% 360
2018
Q4 		$16.6K Buy
359,626
+150,731
+72% +$9.3M 0.04% 407
2018
Q3 		$16.1M Sell
208,895
-20,856
-9% -$1.68M 0.03% 457
2018
Q2 		$19.4M Sell
229,751
-49,077
-18% -$4.28M 0.05% 401
2018
Q1 		$22.8M Sell
278,828
-9,797
-3% -$757K 0.06% 361
2017
Q4 		$16.5M Buy
288,625
+233,925
+428% +$14.7M 0.04% 408
2017
Q3 		$3.65M Buy
54,700
+36,400
+199% +$2.19M 0.01% 697
2017
Q2 		$854K Buy
18,300
+2,100
+13% +$107K ﹤0.01% 829
2017
Q1 		$946K Buy
+16,200
New +$777K ﹤0.01% 820

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management (UK)'s AGIO Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Agios Pharmaceuticals (AGIO) stake by 17% in Q2 2021, selling an estimated $1.22M and leaving 106,557 shares worth $5.87M. The position accounts for 0.01% of the portfolio, ranked #808.

Pictet Asset Management (UK) first reported a position in AGIO in Q1 2017 and has held it in 18 quarters since. The position peaked at $24.5M in Q1 2019. 185 funds tracked by Wall St. Rank hold AGIO as of Q2 2021.

  • Pictet Asset Management (UK) held 106,557 shares of Agios Pharmaceuticals worth $5.87M as of Q2 2021.
  • Pictet Asset Management (UK) sold 21,851 Agios Pharmaceuticals shares in Q2 2021, an estimated $1.22M.
  • Agios Pharmaceuticals made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #808 holding.
  • Pictet Asset Management (UK) first reported a position in Agios Pharmaceuticals in Q1 2017 and has held it in 18 quarters since.
  • Pictet Asset Management (UK)'s Agios Pharmaceuticals position peaked at $24.5M in Q1 2019.
  • 185 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.